… Jacques Genest MD1, Ruth McPherson MD PhD2, Jiri Frohlich MD3, Todd Anderson MD4,
Norm Campbell MD4, André Carpentier MD5, Patrick Couture MD6, Robert Dufour MD7 …

Background Increased levels of the inflammatory biomarker high-sensitivity C-reactive
protein predict cardiovascular events. Since statins lower levels of high-sensitivity C-reactive …

Background Experimental and clinical data suggest that reducing inflammation without
affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory …

The inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) has been proposed
as a novel instrument to assess cardiovascular risk, to determine the need for statin therapy …

BACKGROUND Genetic lipoprotein disorders have been associated with premature coronary
artery disease (CAD). METHODS AND RESULTS The prevalence of such disorders was …

The full text of the updated recommendations is available online (www. cmaj. ca/cgi/content/full/169/9/921/DC1)
lished risk assessment tables. For these reasons and in order to …

The prevalence of abnormalities of lipoprotein cholesterol and apolipoproteins AI and B and
lipoprotein (a) [Lp(a)] was determined in 321 men (mean age 50 ± 7 years) with …

A renin-like enzyme is present in brain tissue and is independent of kidney and plasma
renin. In the presence of homologous substrate it forms angiotensin. Administration of …

… BOUCWER, AND JACQUES GENEST. Renz'n … GENEST. Prcscnce of an angiotensin …
GENEST. Angiotensinforming enzyme in brain tissue. Science …

Since the last publication of the recommendations for the management and treatment of
dyslipidemia, new clinical trial data have emerged that support a more vigorous approach to …